566
Views
85
CrossRef citations to date
0
Altmetric
Review

Preventing surgical site infections

, , , , &
Pages 657-670 | Published online: 10 Jan 2014

References

  • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol.20, 250–278 (1999).
  • Stephan F, Sax H, Wachsmuth M, Hoffmeyer P, Clergue F, Pittet D. Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before–after intervention study. Clin. Infect. Dis.42, 1544–1551 (2006).
  • Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J. Am. Acad. Orthop. Surg.16, 283–293 (2008).
  • Broex EC, van Asselt AD, Bruggeman CA, van Tiel FH. Surgical site infections, how high are the costs?. J. Hosp. Infect.72, 193–201 (2009).
  • Pittet D, Harbarth S, Ruef C et al. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect. Control Hosp. Epidemiol.20, 37–42 (1999).
  • Hawn MT, Itani KM, Gray SH, Vick CC, Henderson W, Houston TK. Association of timely administration of prophylactic antibiotics for major surgical procedures and surgical site infection. J. Am. Coll. Surg.206, 814–819 (2008).
  • Graf K, Sohr D, Haverich A, Kuhn C, Gastmeier P, Chaberny IF. Decrease of deep sternal surgical site infection rates after cardiac surgery by a comprehensive infection control program. Interact. Cardiovasc. Thorac. Surg.9, 282–286 (2009).
  • Park C, Hsu C, Neelakanta G et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation87, 1031–1036 (2009).
  • Lübbeke A, Moons KG, Garavaglia G, Hoffmeyer P. Outcomes of obese and obese patients undergoing revision total hip arthroplasty. Arthritis. Rheum.59, 738–745 (2008).
  • Rioux C, Grandbastien B, Astagneau P. The standardized incidence ratio as a reliable tool for surgical site infection surveillance. Infect. Control Hosp. Epidemiol.27, 817–824 (2006).
  • Trussell J, Gerkin R, Coates B et al. Impact of a patient care pathway protocol on surgical site infection rates in cardiothoracic surgery patients. Am. J. Surg.196, 883–889 (2008).
  • Casey AL, Elliott TS. Progress in the prevention of surgical site infection. Curr. Opinion. Infect. Dis.22, 370–375 (2009).
  • Berwick DM, Calkins DR, McCan CJ, Hackbarth AD. The 100,000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA295, 324–327 (2006).
  • Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg. Infect.9, 579–584 (2008).
  • Haynes AB, Weiser TG, Berry WR et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N. Engl. J. Med.360, 491–499 (2009).
  • Pittet D, Allegranzi B, Boyce J. The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect. Control Hosp. Epidemiol.30, 611–622 (2009).
  • Pittet D, Allegranzi B, Storr J, Donaldson L. ‘Clean Care is Safer Care’: the Global Patient Safety Challenge 2005–2006. Int. J. Infect. Dis.10, 419–424 (2006).
  • Uçkay I, Ahmed QA, Sax H, Pittet D. Ventilator-associated pneumonia as a quality indicator for patient safety?. Clin. Infect. Dis.46, 557–563 (2008).
  • Brümmer S, Brandt C, Sohr D, Gastmeier P. Does stratifying surgical site infection rates by the National Nosocomial Infection Surveillance risk index influence the rank order of the hospitals in a surveillance system?. J. Hosp. Infect.69, 295–300 (2008).
  • Lizioli A, Privitera G, Alliata E et al. Prevalence of nosocomial infections in Italy, result from the Lombardy survey in 2000. J. Hosp. Infect.54, 141–148 (2003).
  • Klavs I, Bufon Luznik T, Skerl M et al. Prevalence of and risk factors for hospital-acquired infections in Slovenia – results of the first national survey, 2001. J. Hosp. Infect.54, 149–157 (2003).
  • Astagneau P, L’Heriteau F, Daniel F et al. Reducing surgical site infection incidence through a network, results from the French ISO-RAISIN surveillance system. J. Hosp. Infect.72, 127–134 (2009).
  • Barnes S, Salemi C, Fithian D et al. An enhanced benchmark for prosthetic joint replacement infection rates. Am. J. Infect. Control34, 669–672 (2006).
  • Mannien J, Wille JC, Snoeren RL, van den Hof S. Impact of postdischarge surveillance on surgical site infection rates for several surgical procedures, results from the nosocomial surveillance network in The Netherlands. Infect. Control Hosp. Epidemiol.27, 809–816 (2006).
  • Manniën J, van den Hof S, Muilwijk J et al. Trends in the incidence of surgical site infection in The Netherlands. Infect. Control Hosp. Epidemiol.29, 1132–1138 (2008).
  • Ibsen Sorensen A, Sandberg Sorensen T, Bremmelgaard A. Quality of the surveillance of surgical wound infections: a 10-year prospective study of 12,364 wounds. Acta. Orthop. Scand.74, 175–179 (2003).
  • Romaniszyn D, Wojkowska-Mach J, Jaje E, Bulanda M, Franczuk B, Heczko PB. Epidemiological and microbiological surveillance of surgical site infections in orthopedic unit. Ortop. Traumatol. Rehabil.8, 639–645 (2006).
  • Uçkay I, Lübbeke A, Emonet S et al. Low incidence of haematogenous seeding to total hip and knee prostheses in patients with remote infections. J. Infect.59, 337–345 (2009).
  • Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med.357, 654–663 (2007).
  • Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J. Hosp. Infect.54, 258–266 (2003).
  • Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med.355, 2725–2732 (2006).
  • Carlet J, Fabry J, Amalberti R, Degos L. The ‘zero risk’ concept for hospital-acquired infections: a risky business! Clin. Infect. Dis.49, 747–749 (2009).
  • Choksey MS, Malik IA. Zero tolerance to shunt infections, can it be achieved?. J. Neurol. Neurosurg. Psychiatry.75, 87–91 (2004).
  • Haridas M, Malangoni MA. Predictive factors for surgical site infection in general surgery. Surgery144, 496–501 (2008).
  • Brandt C, Sohr D, Behnke M, Daschner F, Ruden H, Gastmeier P. Reduction of surgical site infection rates associated with active surveillance. Infect. Control Hosp. Epidemiol.27, 1347–1351 (2006).
  • Thu LT, Dibley MJ, Ewald B, Tien NP, Lam LD. Incidence of surgical site infections and accompanying risk factors in Vietnamese orthopaedic patients. J. Hosp. Infect.60, 360–367 (2005).
  • Saxer F, Widmer A, Fehr J et al. Benefit of a single preoperative dose of antibiotics in a sub-saharan district hospital: minimal input, massive impact. Ann. Surg.24, 322–326 (2009).
  • Maksimovic J, Markovic-Denic L, Bumbasirevic M, Marinkovic J, Vlajinac H. Surgical site infections in orthopedic patients: prospective cohort study. Croat. Med. J.49, 58–65 (2008).
  • Lloyd JC, Braga-Mele R. Incidence of postoperative endophthalmitis in a high-volume cataract surgicentre in Canada. Can. J. Ophthalmol.44, 288–292 (2009).
  • Babcock HM, Carroll C, Matava M, L’Ecuyer P, Fraser V. Surgical site infections after arthroscopy: outbreak investigation and case control study. Arthroscopy.19, 172–181 (2003).
  • Wieck JA, Jackson JK, O’Brien TJ, Lurate RB, Russell JM, Dorchak JD. Efficacy of prophylactic antibiotics in arthroscopic surgery. Orthopedics20, 133–134 (1997).
  • D’Angelo GL, Ogilvie-Harris DJ. Septic arthritis following arthroscopy, with cost/benefit analysis of antibiotic prophylaxis. Arthroscopy4, 10–14 (1988).
  • Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta. Orthop. Scand.71, 337–353 (2000).
  • Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register. Acta. Orthop. Scand.74, 644–651 (2003).
  • Paavolainen P, Hamalainen M, Mustonen H, Slatis P. Registration of arthroplasties in Finland. A nationwide prospective project. Acta. Orthop. Scand.241, 27–30 (1991).
  • Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J. Arthroplasty23, 984–991 (2008).
  • Mahomed NN, Barrett JA, Katz JN et al. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J. Bone Joint Surg. Am.85, 27–32 (2003).
  • Ayliffe GA. Role of the environment of the operating suite in surgical wound infection. Rev. Infect. Dis.13, 800–804 (1991).
  • Boyce JM, Potter-Bynoe G, Opal SM, Dziobek L, Medeiros AA. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J. Infect. Dis.161, 493–499 (1990).
  • Mermel LA, McKay M, Dempsey J, Parenteau S. Pseudomonas surgical-site infections linked to a healthcare worker with onychomycosis. Infect. Control Hosp. Epidemiol.24, 749–752 (2003).
  • Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet1, 795–796 (1981).
  • Webb BG, Lichtman DM, Wagner RA. Risk factors in total joint arthroplasty, comparison of infection rates in patients with different socioeconomic backgrounds. Orthopedics31, 445 (2008).
  • Akça O, Melischek M, Scheck T et al. Postoperative pain and subcutaneous oxygen tension. Lancet354, 41–42 (1999).
  • Beldi G, Bisch-Knaden S, Banz V, Mühlemann K, Candinas D. Impact of intraoperative behavior on surgical site infections. Am. J. Surg.198, 157–162 (2009).
  • Widmer AF, Rotter M, Voss A et al. Surgical hand preparation: state-of-the-art. J. Hosp. Infect.74(2), 112–122 (2009).
  • Niel-Weise BS, Wille JC, van den Broek PJ. Hair removal policies in clean surgery: systematic review of randomized, controlled trials. Infect. Control Hosp. Epidemiol.26, 923–928 (2005).
  • Horgan MA, Kernan JC, Schwartz MS, Kellogg JX, McMenomey SO, Delashaw JB. Shaveless brain surgery, safe, well tolerated, and cost effective. Skull Base Surg.9, 253–258 (1999).
  • Tanner J, Woodings D, Moncaster K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst. Rev.19, CD004122 (2006)
  • Sax H, Allegranzi B, Uçkay I, Larson E, Boyce J, Pittet D. ‘My five moments for hand hygiene’: a user-centred design approach to understand, train, monitor and report hand hygiene. J. Hosp. Infect.67, 9–21 (2007).
  • Pittet D, Hugonnet S, Harbarth S et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet356, 1307–1312 (2000).
  • Rotter M, Sattar SA, Dharan S, Webber P, Voss A, Pittet D. Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am. J. Infect. Control33, 558–560 (2005).
  • Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J. Antimicrob. Chemother.62, 601–607 (2008).
  • Hugonnet S, Pittet D. Hand hygiene –beliefs or science?. Clin. Microbiol. Infect6, 350–356 (2000).
  • Nthumba P, Stepita-Poenaru E, Poenaru D et al. Surgical site infections: a cluster-randomized, cross-over study of the efficacy of plain soap and water versus alcohol-based rub for surgical hand preparation. Presented at: Fifth Decennial International Conference on Healthcare-Associated Infection. Atlanta, GA, USA, 18–22 March 2010.
  • Parienti JJ, Thibon P, Heller R et al. Hand-rubbing with an aqueous alcoholic solution vs. traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA288, 722–727 (2002).
  • Tanner J, Swarbrook S, Stuart J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst. Rev.1, CD004288 (2008).
  • Dharan S, Pittet D. Environmental controls in operating theatres. J. Hosp. Infect.51, 79–84 (2002).
  • Meehan J, Jamali AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J. Bone Joint Surg. Am.91, 2480–2490 (2009).
  • Hayashi MS, Wilson SE. Is there a current role for preoperative-absorbable oral antimicrobial agents for prophylaxis of infection after colorectal surgery?. Surg. Infect.10, 285–288 (2009).
  • Jaeger M, Maier D, Kern WV, Sudkamp NP. Antibiotics in trauma and orthopedic surgery – a primer of evidence-based recommendations. Injury37, 74–80 (2006).
  • Wright TI, Baddour LM, Berbari EF et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J. Am. Acad. Dermatol.59, 464–473 (2008).
  • Charnley J. Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin. Orthop. Relat. Res.87, 167–187 (1972).
  • Fogelberg EV, Zitzmann EK, Stinchfield FE. Prophylactic penicillin in orthopaedic surgery. J. Bone Joint Surg. Am.52, 95–98 (1970).
  • Pavel A, Smith RL, Ballard A, Larson IJ. Prophylactic antibiotics in elective orthopedic surgery: a prospective study of 1,591 cases. South. Med. J.70, 50–55 (1977).
  • Henley MB, Jones RE, Wyatt RW, Hofmann A, Cohen RL. Prophylaxis with cefamandole in elective orthopedic surgery. Clin. Orthop. Relat. Res.209, 249–254 (1986).
  • Lew D, Pittet D, Waldvogel F. Infections that complicate the insertion of prosthetic devices. In: Hospital Epidemiology and Infection Control (3rd Ed.). Mayhall G (Ed.). Williams & Wilkins, MD, USA, 731–748 (2003).
  • Harbarth S, Huttner B, Gervaz P et al. Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection. Infect. Control Hosp. Epidemiol.29, 890–893 (2008).
  • Suffoletta TJ, Jennings HR, Oh JJ, Stephens D, Poe KL. Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study. Pharmacotherapy28, 1133–1139 (2008).
  • Cranny G, Elliott R, Weatherly H et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol. Assess.12, 1–147 (2008).
  • Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI. Does cement increase the risk of infection in primary total hip arthroplasty?. Revision rates in 56,275 cemented and uncemented primary THAs followed for 0–16 years in the Norwegian Arthroplasty Register. Acta. Orthopaedica77, 351–358 (2006).
  • Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med.326, 281–286 (1992).
  • Steinberg JP, Braun BI, Hellinger WC et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann. Surg.250, 10–16 (2009).
  • Weber WP, Marti WR, Zwahlen M et al. The timing of surgical antimicrobial prophylaxis. Ann. Surg.247, 918–926 (2008).
  • McDonald M, Grabsch E, Marshall C, Forbes A. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust. N. Z. J. Surg.68, 388–396 (1998).
  • Mauerhan DR, Nelson CL, Smith DL et al. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J. Bone Joint Surg. Am.76, 39–45 (1994).
  • Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation101, 2916–2921 (2000).
  • Johnson DP. Antibiotic prophylaxis with cefuroxime in arthroplasty of the knee. J. Bone Joint. Surg. Br.69, 787–789 (1987).
  • Barbour A, Schmidt S, Rout WR, Ben-David K, Burkhardt O, Derendorf H. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int. J. Antimicrob. Agents34, 231–235 (2009).
  • Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med.14, 1645–1654 (2004).
  • Glynn MK, Sheehan JM. The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin. Orthop. Relat. Res.185, 151–154 (1984).
  • Koulouvaris P, Sculco P, Finerty E, Sculco T, Sharrock NE. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin. Orthop. Relat. Res.467, 1859–1867 (2009).
  • Aggarwal R, Darzi A. Symposium on surgical simulation for training and certification. World. J. Surg.32, 139–140 (2008).
  • Vincent A, Ayzac L, Girard R et al. Downward trends in surgical site and urinary tract infections after cesarean delivery in a French surveillance network, 1997–2003. Infect. Control Hosp. Epidemiol.29, 227–233 (2008).
  • Rioux C, Grandbastien B, Astagneau P. Impact of a six-year control programme on surgical site infections in France: results of the INCISO surveillance. J. Hosp. Infect.66, 217–223 (2007).
  • Gastmeier P, Sohr D, Schwab F et al. Ten years of KISS: the most important requirements for success. J. Hosp. Infect.70, 11–16 (2008).
  • Geubbels EL, Nagelkerke NJ, Mintjes-De Groot AJ, Vandenbroucke-Grauls CM, Grobbee DE, De Boer AS. Reduced risk of surgical site infections through surveillance in a network. Int. J. Qual. Health. Care18, 127–133 (2006).
  • Haley RW, Culver DH, White JW et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol.121, 182–205 (1985).
  • Pittet D. The Lowbury lecture: behaviour in infection control. J. Hosp. Infect.58, 1–13 (2004).
  • Humphreys H. Preventing surgical site infection. Where now?. J. Hosp. Infect.73, 316–322 (2009).
  • Robicsek A, Beaumont JL, Paule SM et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann. Intern. Med.148, 409–418 (2008).
  • Keshtgar MR, Khalili A, Coen PG et al. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. Br. J. Surg.95, 381–386 (2008).
  • Pofahl WE, Goettler CE, Ramsey KM, Cochran MK, Nobles DL, Rotondo MF. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J. Am. Coll. Surg.208, 981–986 (2009).
  • Harbarth S, Fankhauser C, Schrenzel J et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA299, 1149–1157 (2008).
  • Jeyaratnam D, Whitty CJ, Phillips K et al. Impact of rapid screening tests on acquisition of meticillin-resistant Staphylococcus aureus, cluster randomised crossover trial. Br. Med. J.336, 927–930 (2008).
  • Munoz P, Hortal J, Giannella M et al. Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J. Hosp. Infect.68, 25–31 (2008).
  • van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J. Antimicrob. Chemother.61, 254–261 (2008).
  • Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM et al. Surgical site infections in orthopedic surgery, the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis.35, 353–358 (2002).
  • Perl TM, Cullen JJ, Wenzel RP et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med.346, 1871–1877 (2002).
  • Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections, systematic review of the literature and meta-analysis. Infect. Control Hosp. Epidemiol.26, 916–922 (2005).
  • Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin. Orthop. Relat. Res.466, 1349–1355 (2008).
  • Rao N, Cannella B, Crossett LS, Yates AJ Jr, McGough R 3rd. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin. Orthop. Relat. Res.466, 1343–1348 (2008).
  • Bode LG, Kluytmans JA, Wertheim HF et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med.362, 9–17 (2010).
  • Kumar S, Wong PF, Melling AC, Leaper DJ. Effects of perioperative hypothermia and warming in surgical practice. Int. Wound J.2, 193–204 (2005).
  • Scott EM, Buckland R. A systematic review of intraoperative warming to prevent postoperative complications. AORN J.83, 1090–1104 (2006).
  • Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N. Engl. J. Med.334, 1209–1215 (1996).
  • Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet358, 876–880 (2001).
  • Ambiru S, Kato A, Kimura F et al. Poor postoperative blood glucose control increases surgical site infections after surgery for hepato–biliary–pancreatic cancer, a prospective study in a high-volume institute in Japan. J. Hosp. Infect.68, 230–233 (2008).
  • Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J. Bone Joint Surg. Am.91, 1621–1629 (2009).
  • Kao LS, Meeks D, Moyer VA, Lally KP. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst. Rev.8, CD006806 (2009).
  • Maragakis LL, Cosgrove SE, Martinez EA, Tucker MG, Cohen DB, Perl TM. Intraoperative fraction of inspired oxygen is a modifiable risk factor for surgical site infection after spinal surgery. Anesthesiology110, 556–562 (2009).
  • Belda FJ, Aguilera L, Garcia de la Asuncion J et al. Supplemental perioperative oxygen and the risk of surgical wound infection, a randomized controlled trial. JAMA294, 2035–2342 (2005).
  • Gardella C, Goltra LB, Laschansky E et al. High-concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection, a randomized controlled trial. Obstet. Gynecol.112, 545–552 (2008).
  • Pryor KO, Fahey TJ 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA291, 79–87 (2004).
  • Greif R, Akça O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N. Engl. J. Med.342, 161–167 (2000).
  • Qadan M, Akca O, Mahid SS, Hornung CA, Polk HC Jr. Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials. Arch. Surg.144, 359–366 (2009).
  • Meyhoff CS, Wetterslev J, Jorgensen LN et al. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA302, 1543–1550 (2009).
  • Hunt TK, Hopf HW. High inspired oxygen fraction and surgical site infection. JAMA302, 1588–1589 (2009).
  • Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA296, 2460–2466 (2006).
  • Kollef M, Pittet D, Sanchez Garcia M et al. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med.173, 91–97 (2006).
  • Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin. Infect. Dis.46, 274–281 (2008).
  • Squadrone V, Coha M, Cerutti E et al. Continuous positive airway pressure for treatment of postoperative hypoxemia, a randomized controlled trial. JAMA293, 589–595 (2005).
  • Gaines RJ, Dunbar RP. The use of surgical drains in orthopedics. Orthopedics31, 702–705 (2008).
  • Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst. Rev.2, CD004985 (2007).
  • Darouiche RO, Wall MJ Jr, Itani KM et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N. Engl. J. Med.362, 18–26 (2010).
  • Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int. Wound J.5, 376–387 (2008).
  • Stonecypher K. Going around in circles: is this the best practice for preparing the skin?. Crit. Care. Nurs. Q.32, 94–98 (2009).
  • Zhao X, Chen J, Fang XQ, Fan SW. Surgical site marking will not affect sterility of the surgical field. Med. Hypotheses73, 319–320 (2009).
  • Laine T, Aarnio P. Glove perforation in orthopaedic and trauma surgery. A comparison between single, double indicator gloving and double gloving with two regular gloves. J. Bone Joint Surg. Br.86, 898–900 (2004).
  • Misteli H, Weber WP, Reck S et al. Surgical glove perforation and the risk of surgical site infection. Arch. Surg.144, 553–558 (2009).
  • Thomas S, Agarwal M, Mehta G. Intraoperative glove perforation-single versus double gloving in protection against skin contamination. Postgrad. Med. J.77, 458–460 (2001).
  • Tanner J, Parkinson H. Double gloving to reduce surgical cross-infection. Cochrane Database Syst. Rev.3, CD003087 (2006).
  • Webster J, Alghamdi AA. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst. Rev.4, CD006353 (2007).
  • Horgan MA, Piatt JH Jr. Shaving of the scalp may increase the rate of infection in CSF shunt surgery. Pediatr. Neurosurg.264, 180–184 (1997).
  • Whyte W, Hodgson R, Tinkler J. The importance of airborne bacterial contamination of wounds. J. Hosp. Infect.3, 123–135 (1982).
  • Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br. Med. J.285, 10–14 (1982).
  • Brandt C, Hott U, Sohr D, Daschner F, Gastmeier P, Ruden H. Operating room ventilation with laminar airflow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Ann. Surg.248, 695–700 (2008).
  • Lipsett PA. Do we really need laminar flow ventilation in the operating room to prevent surgical site infections?. Ann. Surg.248, 701–703 (2008).
  • Slim K, Vicaut E, Launay-Savary MV, Contant C, Chipponi J. Updated systematic review and meta-analysis of randomized clinical trials on the role of mechanical bowel preparation before colorectal surgery. Ann. Surg.249, 203–209 (2009).
  • Mullen JC, Bentley MJ, Mong K et al. Reduction of leg wound infections following coronary artery bypass surgery. Can. J. Cardiol.15, 65–68 (1999).
  • Chughtai T, Chen LQ, Salasidis G, Nguyen D, Tchervenkov C, Morin JF. Clips versus suture technique: is there a difference?. Can. J. Cardiol.16, 1403–1407 (2000).
  • Cohn SM, Giannotti G, Ong AW et al. Prospective randomized trial of two wound management strategies for dirty abdominal wounds. Ann. Surg.233, 409–413 (2001).
  • Duttaroy DD, Jitendra J, Duttaroy B et al. Management strategy for dirty abdominal incisions: primary or delayed primary closure?. Surg. Infect.10, 129–136 (2009).
  • Wilson SE. Microbial sealing: a new approach to reducing contamination. J. Hosp. Infect.70, 11–14 (2008).
  • W-Dahl A, Toksvig-Larsen S, Lindstrand A. No difference between daily and weekly pin site care: a randomized study of 50 patients with external fixation. Acta Orthop. Scand.7, 704–708 (2003).
  • Lethaby A, Temple J, Santy J. Pin site care for preventing infections associated with external bone fixators and pins. Cochrane Database Syst. Rev.CD004551 (2008).
  • Eggimann P, Pittet D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin. Microbiol. Infect.8, 295–309 (2002).
  • Dosseh Eacute Koue D, Doleaglenou A, Fortey YK, Ayite AE. Randomized trial comparing dressing to no dressing of surgical wounds in a tropical setting. J. Chir. (Paris)145, 143–146 (2008).
  • Cosker T, Elsayed S, Gupta S, Mendonca AD, Tayton KJ. Choice of dressing has a major impact on blistering and healing outcomes in orthopaedic patients. J. Wound Care14, 27–29 (2005).
  • Vermeulen H, Ubbink D, Goossens A, de Vos R, Legemate D. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst. Rev.CD003554 (2004).
  • Shinohara T, Yamashita Y, Satoh K et al. Prospective evaluation of occlusive hydrocolloid dressing versus conventional gauze dressing regarding the healing effect after abdominal operations, randomized controlled trial. Asian J. Surg.31, 1–5 (2008).
  • Ubbink DT, Vermeulen H, Goossens A, Kelner RB, Schreuder SM, Lubbers MJ. Occlusive vs. gauze dressings for local wound care in surgical patients: a randomized clinical trial. Arch. Surg.143, 950–955 (2008).
  • Wynne R, Botti M, Stedman H et al. Effect of three wound dressings on infection, healing comfort, and cost in patients with sternotomy wounds: a randomized trial. Chest125, 43–49 (2004).
  • Humphreys H, Cunney R. Performance indicators and the public reporting of healthcare-associated infection rates. Clin. Microbiol. Infect.14, 892–894 (2008).
  • McCall JL, Macchiaroli S, Brown RB et al. A method to track surgical site infections. Qual. Manag. Health Care6, 52–62 (1998).
  • McKibben L, Horan T, Tokars JI et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am. J. Infect. Control33, 217–226 (2005).
  • McKibben L, Fowler G, Horan T, Brennan PJ. Ensuring rational public reporting systems for health care-associated infections: systematic literature review and evaluation recommendations. Am. J. Infect. Control34, 142–149 (2006).
  • Petrosillo N, Drapeau CM, Nicastri E, Martini L, Ippolito G, Moro ML. Surgical site infections in Italian Hospitals: a prospective multicenter study. BMC Infect. Dis.8, 34–45 (2008).
  • Kompatscher P, von Planta A, Spicher I et al. Comparison of the incidence and predicted risk of early surgical site infections after breast reduction. Aesthetic. Plast. Surg.27, 308–314 (2003).
  • Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect. Dis.5, 94–106 (2005).
  • Smith RL, Bohl JK, McElearney ST et al. Wound infection after elective colorectal resection. Ann. Surg.239, 599–605 (2004).
  • Wick EC, Gibbs L, Indorf LA, Varma MG, Garcia-Aguilar J. Implementation of quality measures to reduce surgical site infection in colorectal patients. Dis. Colon Rectum51, 1004–1009 (2008).
  • Kleinert JM, Hoffmann J, Miller Crain G, Larsen CF, Goldsmith LJ, Firrell JC. Postoperative infection in a double-occupancy operating room. A prospective study of two thousand four hundred and fifty-eight procedures on the extremities. J. Bone Joint Surg. Am.79, 503–513 (1997).
  • Merrer J, Girou E, Lortat-Jacob A, Montravers P, Lucet JC. Surgical site infection after surgery to repair femoral neck fracture: a French multicenter retrospective study. Infect. Control Hosp. Epidemiol.28, 1169–1174 (2007).
  • Parameswaran AD, Roberts CS, Seligson D, Voor M. Pin tract infection with contemporary external fixation: how much of a problem?. J. Orthop. Trauma17, 503–507 (2003).
  • Zgonis T, Jolly GP, Garbalosa JC. The efficacy of prophylactic intravenous antibiotics in elective foot and ankle surgery. J. Foot Ankle Surg.43, 97–103 (2004).
  • Popelka S, Vavrik P, Hromadka R, Sosna A. Our results of the Lapidus procedure in patients with hallux valgus deformity. Acta Chir. Orthop. Traumatol. Cech.75, 271–276 (2008).
  • Kürklü M, Demiralp B, Yurttaş Y, Çiçek EI, Ateşalp AS. Modified chevron osteotomy fixed with stofella pin for hallux valgus. Foot Ankle Int.29, 478–482 (2008).
  • Campbell DA Jr, Henderson WG, Englesbe MJ et al. Surgical site infection prevention, the importance of operative duration and blood transfusion – results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J. Am. Coll. Surg.207, 810–820 (2008).
  • Alexander JW, Fischer JE, Boyajian M, Palmquist J, Morris MJ. The influence of hair-removal methods on wound infections. Arch. Surg.118, 347–352 (1983).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.